The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
"A concrete sale is better than jam tomorrow."
I disagree. Concrete retails for about £115 a ton (depending on grade), so about 0.35p per ounce.
Jam, at about £1.20 for a 1lb jar, is about 7.5p an ounce.
Waiting until tomorrow (1/365th of a year) for an uplift of 214% (from 0.35p to 7.5p) works out a non-compounding return of 78,110%, or 78 times your money.
Worth waiting for, in my book.
Yeah, FFS BoD, how about you publicly goat in Putin's face about how you're going to take all the value out of his precious resources and pay the evil West with the proceeds, long before the transaction happens so that Putin has time to sanction us.
I assess the facts as presented by some incredible research over the years on here and Telegram. I feel I understand them enough to invest and stay invested, irrespective of the share price or timeline.
That's why I am confident I can ignore your deramping as much as Tilly's ramping. It's all just irrelevant (albeit entertaining) noise.
I disagree, CALLS. Look at Genedrive. They've sold nothing ever and burnt through a ton of cash in recent years. The CEO David Budd is paid £400k pa but holds only a tiny amount of shares which he only bought just before the last AGM when there was a risk he would be sacked. During all this time their RNSs have been absolutely minimal and in the case of one, actually intentionally detrimental to the share price (India signing up to distribute their PCR test). David Budd has had nothing but distain for the shareholders, and brazenly openly shows contempt for shareholder value.
Then there's Vlad Sandler over at Hemogenyx who tanked the share price through his own arrogance by signing up to death spiral financing with Mint Capital's CDO palcement funding. He has never once claimed to run the business for the shareholders - only for his personal ambition to get his own CAR-T therapy on the open market to cure the leukemia his father died from. Again, minimal/non-existant RNSs and no pumping the SP for shareholders to get out.
I could go on about Colin Bird at Bezant too....
They're keeping their head down, as quietly as possible, and do not want to attract the interests of the wider media, regulatory authorities, government ministers, etc. on both sides of the iron curtain.
Seriously, you sound like the kind of guy who'd shout up at Anne Frank's loft "Hey Anne, the Germans are coming, did you hear me, why won't you answer me?!"
When companies similar to ours are regularly being sanctioned, when fire sales such as Kinross are happening, and when the AIM market is full of pump and dump BODs who deliver nothing but rack up debt and placements, I'm actually very happy that our BOD is keeping their head down and playing the long patient game.
If you think the artificial support of the share price through pumping out a regular "hey - look at us!" news stream should be the BOD's priority right now, we may have to agree to disagree.